co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Meghana V Malkan of malkansview.com advises buying Voltas with a target of Rs 240-245 and selling Crompton Greaves with a target of Rs 183-178.
Krish Subramanyam of Asit C Mehta Investment Intermediates is of the view that one can buy Alembic for a target price of Rs 47 and Indian Oil Corporation for a target price of Rs 410.
Dharmesh Kant, IndiaNivesh Securities Private Limited advises buying Federal Bank for a target price of Rs 134 and SKS Microfinance for a target price of Rs 360.
Kunal Bothra of LKP advises buying Escorts with a target of Rs 155 and Dishman Pharma with a target of Rs 182-183.
Meghana V Malkan of malkansview.com advises buying Crompton Greaves with a target of Rs 235-242 and India Cements with a target of Rs 126-132.
Hemen Kapadia of KR Choksey Securities suggests buying Aurobindo Pharma with a target of Rs 844 and selling Century Textiles and Industries with a target of Rs 623.
According to CNBC-TV18‘s research team following are the stocks to focus on Dr Reddy's, BPCL, Ranbaxy, Dishman Pharma, Bank of Baroda, Ashok Leyland, Jaiprakash Assoc, Crompton Greaves, Eicher Motors and Infotech Ent.
Akshata Deshmukh of Networth Capital recommends buying India Cements for a target of Rs 59.50 and Dishman Pharmaceuticals & Chemicals for a target of Rs 96.
Ambareesh Baliga of Edelweiss Financial Services is of the view that Dishman Pharmaceuticals & Chemicals may test Rs 135-140.
Vishal Malkan, Malkansview advises buying Cox & Kings for a target price of Rs 158 and Bata India for a target price of Rs 1120.
Pritesh Mehta of IIFL suggests buying Dishman Pharmaceuticals & Chemicals with a target of Rs 96 and IDFC with a target of Rs 109.
Ambareesh Baliga of Edelweiss Financial Services is of the view that one may prefer Sun Pharmaceutical Industries, Lupin, Dishman Pharmaceuticals & Chemicals and Shasun Pharmaceuticals from the pharma space.
Sudarshan Sukhani of s2analytics.com is of the view that one may hold on to Dishman Pharmaceuticals & Chemicals as the stock is begining its bull market.
Sudarshan Sukhani of s2analytics.com recommends buying Dishman Pharmaceuticals & Chemicals.
Pritesh Mehta, Senior Technical Analyst at IIFL recommends buying Dishman Pharmaceuticals & Chemicals as the stock may test Rs 109 in the next couple of days.
Sudarshan Sukhani of s2analytics.com is of the view that Dishman Pharmaceuticals & Chemicals may test Rs 105-110.
Rakesh Gandhi, independent technical analyst recommends buying Dishman Pharmaceuticals & Chemicals with a target of Rs 104.50 and Arvind with a target of Rs 141.75.
According Pritesh Mehta of IIFL, one may buy Shriram Transport Finance Corporation with a target of Rs 640.
Ambareesh Baliga of Edelweiss Securities is of the view that one may pick Bharat Forge, Motherson Sumi Systems and Dishman Pharma.
According to Manav Chopra of Nirmal Bang, one may buy Dishman Pharmaceuticals & Chemicals with a target of Rs 85 and ING Vysya Bank with a target of Rs 635.
Ambareesh Baliga of Edelweiss Financial Services feels Dishman Pharmaceuticals & Chemicals may test a target price of Rs 110 as its September quarter results were strong.
Manav Chopra of Nirmal Bang advises buying CESC for a target price of Rs 405 and SREI Infrastructure for a target price of Rs 24.2.
Ambareesh Baliga, Managing Partner-Global Wealth Management of Edelweiss Financial Services is of the view that Dishman Pharmaceuticals & Chemicals may test Rs 110-120.
Kunal Bothra, Head of Advisory at LKP recommends holding Dishman Pharmaceuticals and Chemicals. “The stock may go up to Rs 75-80 in next six-eight months,†he adds.
Phani Sekhar of Angel Broking advises holding Dishman Pharmaceuticals & Chemicals for long term.
